Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

During the Trading Day
32.77 -0.75 / -2.24%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
32.87 +0.0972 / +0.30%
 
Volume: 4.7K

Today’s Trading

Previous close33.52
Today’s open33.38
Day’s range32.65 - 33.48
Volume434,223
Average volume (3 months)338,754
Market cap$1.7B
Dividend yield--
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)-7.73%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)-3.00%
P/E ratio66.3
Price/Sales2.53
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
PODDInsulet Corp-2.88-9.28%
MASIMasimo Corp-1.58-4.30%
ICUIICU Medical Inc-2.56-2.88%
PENPenumbra Inc-1.51-3.33%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 25, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$910.4M
Annual profit (last year)$16.9M
Net profit margin1.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Ronald G. Gelbman
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers